before treatment , patients ( n = 25 ) had median serum concentrations of testosterone , oestradiol , non-protein bound oestradiol , non-sex hormone binding globulin ( shbg ) bound oestradiol and oestrone sulphate which did not differ significantly from those of healthy controls ( n = 16 ) , but the patients had significantly ( p less than 0.01 ) higher median serum concentrations of oestrone , luteinizing hormone ( lh ) , follicle-stimulating hormone ( fsh ) and prolactin .
C0059668
oestrone sulphate
C0014942
oestrone